n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, March 1st, 2018

The QualityStocks
Daily Stock List

graphic
graphic

Gopher Protocol, Inc. (GOPH)

Profitable Trader Authority, PennyTrader, OTCtipReporter, Wall Street Mover, PennyStockScholar, and Integrity Solution IR reported on Gopher Protocol, Inc. (GOPH), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Gopher Protocol, Inc. is developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled mobile technology. The Company provides a mobile technology for computing power enhancement, advanced mobile database management/sharing, and additional features.

Gopher Protocol’s Integrated Circuit (IC), called GopherInsight™, and accompanied software, creates a private and secured network for sharing information and adapting to user preferences. The system is self-learning and constantly developing. A development stage company, Gopher Protocol is headquartered in Santa Monica, California.

The Company is developing a real-time, heuristic based, mobile technology. When developed, the mobile technology will consist of a smart microchip, mobile application software and supporting software that run on a server. The system envisions the creation of an international network.

The heart of this system will be its advanced microchip, which will be able to undergo installation in any mobile device worldwide. Gopher Protocol expects that this will result in an internal, private network between all mobile devices using the device through providing mobile technology for computing power enhancement, advanced mobile database management/sharing, and more mobile features.

Gopher Protocol has its licensed technology, the Guardian Patch. The mobile tracking technology will track and protect anything one cares about, with or without GPS (Global Positioning System).

The Guardian Patch is a stick-on tracking device. It protects and tracks everything from a phone to a loved-one or a pet. The Guardian Patch device was conceived as an offshoot of Gopher Protocol’s microchip technology named GopherInsight™.

Gopher Protocol introduced its "dDrone" technology in November 2017. This technology uses Artificial Intelligence (AI) to create what is believed to be the world's first" Smart Drone." Gopher AI drone technology uses machine learning to give drones advanced flight capabilities.

Gopher's AI drone technology can solve complex problems related to geo-locations, weather conditions, and obstacle avoidance. The dDrone AI system is equipped with deep learning, resembling IBM's Watson.

Last month, Gopher Protocol announced that it incorporated UGopherServices Limited in England and Wales. With this incorporation of UGopherServices Limited, Gopher Protocol is looking to expand its platform worldwide. The Company formed UGopherServices Limited, which will operate as a wholly-owned subsidiary.

In addition, in February, Gopher Protocol reported new research and development (R&D) efforts for its MESH Technology. New research includes testing of the Company’s MESH network technology for use in autonomous driving tracking and safety applications. Gopher Protocol’s core tracking technology is founded on AI data in real-time and is presently implemented in the Company’s pet tracking device.

The MESH network is a communications network. It is intended to be made up of radio nodes organized in a mesh topology. A mesh refers to rich interconnection among devices or nodes. Wireless mesh networks frequently consist of mesh clients, mesh routers, as well as gateways.

Gopher Protocol, Inc. (GOPH), closed Thursday's trading session at $1.71, up 1.18%, on 164,421 volume with 263 trades. The average volume for the last 60 days is 350,897 and the stock's 52-week low/high is $0.16/$3.15.

Concierge Technologies, Inc. (CNCG)

OnPointStockAlert, Penny Stock Prodigy, Penny Stock Titans, ProTrader, The Street, TopPennyStockMovers, Epic Stock Picks, Nebula Stocks, MicrocapVoice, OTCPicks, PennyStocks24, Pumps and Dumps, EpicVIP Group, MomentumOTC, and Light Speed Stocks reported earlier on Concierge Technologies, Inc. (CNCG), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Concierge Technologies, Inc. operates by way of its wholly-owned subsidiary company Kahnalytics, Inc., and also operates via Brigadier Security Systems and Wainwright Holdings. In addition, the Company acquired Gourmet Foods. Ltd. of Tauranga, New Zealand. Concierge Technologies is based in Valley Center, California. The Company now operates on a global scale with wholly-owned subsidiaries in the United States, New Zealand, and Canada.

In June of 2015, Concierge Technologies founded Kahnalytics, Inc. Kahnalytics is a U.S. based provider of live streaming mobile video, vehicle tracking, and driver behavior data.

Furthermore, USCF is a subsidiary of Concierge Technologies. USCF operates on the vanguard of product innovation as an asset management firm offering exchange-traded products (ETPs), exchange-traded funds (ETFs), as well as mutual funds.

Gourmet Foods is a well-established producer of popular New Zealand meat pies and bakery products under recognized supermarket brand names “Pat’s Pantry” and “Ponsonby Pies”. Gourmet Foods products are in convenience stores, major supermarkets, petrol stations, and restaurants. Gourmet Foods distributes more than 30 products across New Zealand.

On June 2, 2016, Concierge Technologies acquired Brigadier Security Systems of Saskatoon, Saskatchewan. Brigadier is an alarm installation and monitoring company. It is a long-standing security alarm business serving the Province of Saskatchewan since 1985.

Brigadier has security solutions ranging from products designed to protect residential premises and property through to complex access control and camera monitoring equipment. Brigadier Security Systems operates under the trade name Elite Security.

In December 2017, Concierge Technologies announced that its wholly-owned California subsidiary Kahnalytics acquired all of the assets and business of Original Sprout LLC, a California Limited Liability Company (OS). As of December 19, 2017, Kahnalytics started operations under the fictitious business name "Original Sprout" from its location in San Clemente, California. The transition of the former Kahnalytics live-streaming business to the business of Original Sprout has now been completed.

Original Sprout is a manufacturer and distributor of clean, non-toxic, all-natural hair care and skin products. It was founded by master hair stylist Inga Tritt in 2003.

Concierge Technologies, Inc. (CNCG), closed Thursday's trading session at $1.25, even for the day, on 800 volume with 2 trades. The average volume for the last 60 days is 318 and the stock's 52-week low/high is $0.729/$3.00.

Timberline Resources Corp. (TLRS)

InvestorsHub, MarketWatch, and Gold Investment Letter reported on Timberline Resources Corp. (TLRS), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Timberline Resources Corp. is a gold exploration and development company. Its operational focus is the State of Nevada. The Company’s flagship Talapoosa Project is a partially permitted, open-pit, heap leach gold project with low capital and operating costs and strong economics. Additionally, its exploration efforts have been centered on its 23 square-mile Eureka land package. This is one of the largest remaining undeveloped gold properties in Nevada. Timberline Resources is headquartered in Coeur d’Alene, Idaho.

The Company entered into a transaction with Gunpoint Exploration Ltd. on March 17, 2015. Timberline Resources acquired the option to purchase 100 percent of the Talapoosa project, positioned in Lyon County, Nevada. The Talapoosa property is a low-sulphidation gold/silver property in the Walker Lane gold trend of western Nevada, roughly 45 kilometers east of Reno.

Talapoosa highlights include an NI 43-101 resource consisting 1,012,802 oz gold (M&I); 233,532 oz gold (Inferred). Furthermore, highlights include near-surface oxide gold ounces totaling 162,581 oz (M&I); 47,745 oz (Inferred).

Talapoosa has well-established infrastructure. The Talapoosa project in Lyon County is where the Company has completed and disclosed a positive Preliminary Economic Assessment (PEA).

Concerning the Eureka land package, it includes Timberline’s Lookout Mountain project and a pipeline of earlier-stage projects, which feature past gold production, historic gold estimates, and/or drill-indicated gold mineralization. Eureka is on the south end of Nevada’s Battle Mountain/Eureka Trend.

At Eureka, Timberline Resources continues to advance its Lookout Mountain and Windfall project areas. In 2012, the Company purchased a large block of patented and unpatented mining claims. These comprise chiefly the entire Seven Troughs gold mining district near Lovelock in Pershing County, Nevada.

The purchased property package encompasses 4,100 acres. It consists of 64 patented and 238 unpatented lode mining claims, all which are under a long-term lease agreement, along with 162 additional unpatented lode mining claims.

Recently, Timberline Resources announced consolidated financial results for its first Fiscal Year (FY) 2018 quarter ended December 31, 2017. The Company reported a consolidated Net Loss of $0.3 million for the quarter ended December 31, 2017. This includes exploration expenditures of $26,000.

Timberline Resources completed a private placement during the quarter. The Company continues to seek capital for the advancement of the Talapoosa gold and silver project. It expects, subject to having sufficient capital, to continue to advance the Talapoosa project toward a pre-feasibility study and further development.

Timberline Resources Corp. (TLRS), closed Thursday's trading session at $0.17, down 5.56%, on 201,665 volume with 45 trades. The average volume for the last 60 days is 37,072 and the stock's 52-week low/high is $0.13/$0.52.

AmpliTech Group, Inc. (AMPG)

Trading Wall St, fusionspicks, Jet-Life Penny Stocks, OTCMagic, Ascending Stocks, Penny Stock Gainers, RockingPennyStocks, BestStocksDaily, Wallstreetbuzz, AllPennyStocks, SmallCapVoice, PennyStocks24, Information Solutions Group, Pumps and Dumps, HoleinOneStocks.net, HotStockProfits, and Fortune Penny Stocks reported on AmpliTech Group, Inc. (AMPG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AmpliTech Group, Inc. designs, develops, and manufactures custom and standard state-of-the-art RF Low Noise Amplifiers (LNA) and Power Amplifiers (PA). These are for the domestic and global, SATCOM, Space, and Military markets. Additionally, the Company provides consulting services to help with any microwave components or systems design problems. AmpliTech sells its products by way of sales representatives and distributors in North America, Europe, and Asia. OTCQB-listed, AmpliTech Group is based in Bohemia, New York.

The Company’s designs cover the frequency spectrum from 50 kHz to 40 GHz – eventually providing designs up to 100 GHz. AmpliTech can provide complex, custom solutions for almost any custom requirements presented to it. It can provide contract assembly of customers' own designs.

AmpliTech provides its customers with consulting services for their system development. In addition, the Company provides technical assistance in integration and packaging technologies and microwave sub-systems and amplifier related sub-assemblies.

AmpliTech utilizes the most contemporary CAD microwave simulation technology to design and develop from concept to final manufacture of a deliverable product with first-rate accuracy. AmpliTech expects to release new products targeted at the wireless and satellite markets, which will provide advanced technology and performance.

AmpliTech Group announced in 2017 that it entered into a Joint Venture (JV) Agreement with Trusted Networks, Inc. (TN). TN is a New York, New York based private company with facilities in Colorado Springs and Nashua, New Hampshire.

The emphasis of this JV is to develop an affordable mixed signal chipset that can be used at server/router level and also in mobile PDA applications to provide secure and encrypted communication with the goal of preventing hacking and cyber-attacks.

This JV will take advantage of AmpliTech's industry leadership and experience in RF/Microwave LNA technology and TN's Cyber-security Protocol technology to eliminate the widespread occurrence of corporate and individual cyber-attacks.

In November, Amplitech Group announced the filing of its 10-Q for Q3 2017. AmpliTech reported a decline in gross revenues of 24 percent versus the same period the year prior. The Company experienced its second consecutive quarter with reduced revenue.

However, AmpliTech continued its path towards enhancing and expanding its niche product line and technology through investing in research and development (R&D) in higher margin products for commercial applications. In addition, AmpliTech has invested substantially more into advertising and marketing than any other year in its history.

AmpliTech Group, Inc. (AMPG), closed Thursday's trading session at $0.0599, up 24.79%, on 268,335 volume with 21 trades. The average volume for the last 60 days is 93,560 and the stock's 52-week low/high is $0.0296/$0.396.

Secova Metals Corp. (SEKZF)

Stockhouse, Junior Mining Network, InvestorsHub, MarketWatch, Barchart, 4-Traders, The Street, and Stockwatch reported on Secova Metals Corp. (SEKZF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Secova Metals Corp. concentrates on building a strong asset base through the exploration of undervalued projects in Canada. The Company’s Management has demonstrated expertise in advancing gold exploration projects into acquisition targets, most notably in the Province of Quebec. Secova Metals has its corporate headquarters in Vancouver, British Columbia (B.C.). The Company’s shares trade on the OTC Markets Group’s OTCQB.

Secova Metals has the exclusive right and option to acquire from Tres-Or Resources, Inc., an undivided 65 percent right, title, and interest in the contiguous Duvay/Chenier Gold Projects. The Company can earn up to 90 percent of the property (an additional 25 percent ownership) by funding a pre-feasibility study after the initial exploration expenditures to bring the property towards production.

Secova Metals has a total contiguous land package of 174 claims encompassing more than 7,766 hectares (17,458 acres) of land. Duvay/Chenier is situated in the Abitibi gold belt. The Company has plans to advance the development of Duvay/Chenier and look for other avenues of growth by way of acquisition and mergers.

In addition, Secova has 100 percent ownership of the Eagle River project (21,920 contiguous hectares). Eagle River is adjacent to and on-trend to a number of gold projects in the Windfall Lake district of Urban Barry in the Province of Quebec.

This past December, Secova Metals and Tres-Or Resources Ltd. announced gold assay results from the Northern shear zone at the Duvay-Chenier Gold Project. The Northern shear zone results are the first results from Secova Metals’ Phase I exploration program. This program consisted of 20 drill holes totaling 3207 m, and testing three main target areas.

The most significant results from the Northern shear zone were obtained in hole DUV17-01. It intersected 5.4 m of gold-bearing deformed quartz vein material and considerable concentrations of sulfides and black schist.

Laura Lee Duffett, Tres-Or Resources’ President, said, "We are very pleased with the gold assay results from the northern shear zone as they show mineralization extends 300 to 400 m north of the Duvay Main Shear and Zone Principal where most of the historic work and high gold values are located."

Regarding the Duvay/Chenier Project, Secova Metals recently disclosed that based on preliminary results from its first phase of exploration, it is proceeding with Phase 2 of its exploration program at the Duvay/Chenier project.

Moreover, concerning the Eagle River Project, the Company completed the preliminary exploration program on one-third of its Eagle River project adjacent to the Windfall Lake gold camp. This is a grassroots project. Nonetheless, Secova performed an advanced VTEM airborne survey program that identified 19 anomalies.

In addition, Secova Metals announced that with its mandate to acquire and explore undervalued mineral projects in Quebec, it is reviewing more cobalt property acquisitions to potentially add to its cobalt portfolio.

This week, Secova Metals announced that it acquired 1151640 B.C. Ltd. This is a private B.C. Company which sole assets are the Muskrat, Boudrais and Peribonka-Begin Cobalt Projects that comprise 40 claims or roughly 2,186 hectares in eastern Quebec.

Secova Metals’ plan is to immediately start initial airborne mag surveys to delineate targets on the new properties along with its wholly-owned Cobalt Bay project. This could be subsequently followed up with detailed ground exploration programs.

The three projects now comprise Secova Metals’ cobalt project portfolio, along with the Cobalt Bay Project, which is 102 km north of the Company’s Eagle River Project in the Windfall Lake area of Quebec and 209 km north northeast of its Duvay/Chenier project near Amos.

Secova Metals Corp. (SEKZF), closed Thursday's trading session at $0.0244, up 62.67%, on 95,500 volume with 4 trades. The average volume for the last 60 days is 21,528 and the stock's 52-week low/high is $0.0107/$0.069.

Integrated Ventures, Inc. (INTV)

TradingView, MarketWatch, YCharts, OTC Markets, InvestorsHub, Barchart, and Investors Hangout reported on Integrated Ventures, Inc. (INTV), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Integrated Ventures, Inc. concentrates on operating subsidiaries in the digital currency sector. The Company previously went by the name EMS Find, Inc. It changed its corporate name to Integrated Ventures, Inc. in July of 2017. Integrated Ventures is headquartered in Huntingdon Valley, Pennsylvania.

At present, the Company’s crypto portfolio includes BitcoLab – cryptocurrency mining and investing. It also includes Nemesis – manufacturing and sales of mining rigs and equipment.

Its portfolio also includes LoanFunder – the financial platform, designed to integrate with a decentralized and encrypted lending ledger. It offers a secure, efficient, verifiable, and permanent way of storing loan related information. Furthermore, Integrated Ventures’ crypto portfolio includes MMC – the manufacturing, marketing and operating of mobile mining centers.

In January 2018, Integrated Ventures announced that on January 25, 2018, it placed a Purchase Order with Bitmain Technologies for 140 mining rigs and related mining equipment. The expectation is that all newly purchased rigs will be deployed in the Company's new mining facility.

Last month, Integrated Ventures announced the signing of an Authorized Reseller Agreement with Shenzhen Halley Cloud Technology Company. Shenzhen Halley is the exclusive manufacturer of PandaMiners.

PandaMiner is a GPU integrated altcoin mining device. It supports manifold hashing algorithms, such as ETH and other cryptocurrencies. PandaMiner is assembled utilizing a high configuration graphics card, a customized and highly compatible case, and other optimized accessories for the highest mining efficiency.

With this Agreement, Integrated Ventures agreed to purchase 50 PandaMiner B3 Pro mining rigs with a total purchase value of $213,500. This cost includes 50 Power Source Units (valued at $6,250) and DHL shipping (valued at $3,750).

Moreover, in February, Integrated Ventures announced that it acquired CreditCalc from ITBS, LLC, a high-end loan management and calculation platform. The expectation is that this stock based transaction will speed up the development lifecycle of Integrated Ventures’ blockchain based lending platform - LoanFunder.

CreditCalc permits borrowers and lenders to perform complex calculations related to all kinds of loans. These include business loans, car loans, mortgages, as well as other financial instruments. Additionally, CreditCalc provides users an access to the custom credit programs and the ability to shop and compare for different kinds of loan products.

Recently, Integrated Ventures reported the filing with the SEC (Securities and Exchange Commission), of its Quarterly Report (Form 10-Q), for its Q2, ended December 31, 2017.

During the three months ended December 31, 2017, the Company reported Revenues totaling $105,088, comprising $59,498 in mining fees and $45,590 in mining equipment sales. The Cost of Revenues was $46,818. This resulted in a Gross Profit of $58,270 and Profit Margins of 55 percent.

Integrated Ventures, Inc. (INTV), closed Thursday's trading session at $1.40, up 1.45%, on 40,469 volume with 41 trades. The average volume for the last 60 days is 369,231 and the stock's 52-week low/high is $0.0008/$6.74.

Yappn Corp. (YPPN)

SmallCapFinancialWire, PennyStocks24, Shiznit Stocks, Stock Shock and Awe, StockRunway, Orbit Stocks, MyBestStockAlerts, Fast Money Alerts, Penny Stock General, TopPennyStockMovers, SmallCapVoice, Information Solutions Group, and Social Hot Dog reported previously on Yappn Corp. (YPPN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Yappn Corp. is a real-time unique language solutions enterprise that amplifies brand messaging, helps conduct commerce, and provides customer support through globalizing these experiences with its proprietary approach to language. Established in 2010, Yappn provides people and brands the power to be social, conduct commerce, and communicate freely without a language barrier.

Yappn has its headquarters in Markham, Ontario. The Company lists on the OTC Markets’ OTCQB. The Company was previously known as Plesk Corp. It changed its name to Yappn Corp. in March of 2013.

In essence, Yappn approaches the challenge of real-time language translation in a completely innovative manner. The result is enhanced translations based on the context of the content or discussion. Consequently, this substantially improves the translation result. According to Common Sense Advisory, more than 72 percent of consumers say they are more likely to purchase online if the experience is in their preferred language.

Backed by its proprietary technology, Yappn’s advanced algorithms return translation with the correct meaning and context of the message. It does so in real-time. The Company’s system is constructed on an enterprise development methodology. It is hosted on Microsoft’s Azure® cloud-based platform.

Yappn provides products for ecommerce, customer care, enhanced messaging collaboration, and online marketing. Furthermore, the Company provides custom translation solutions to different verticals. These include entertainment, retail, as well as marketing.

Yappn has its e-translation product. This is an advanced product that provides global vendors with the ability to integrate into leading ecommerce marketplace sites.

Yappn offers a complete customizable set of tools to engage consumers in more than 100 languages. Yappn is free for users who want to participate on the Company’s general discussion board, unless otherwise noted.

A user’s language is detected by their browser setting automatically. At the very bottom of the page, a user will find a translator bar with the option to choose many languages. A user selects their language and all Yappn pages immediately translate. Everything a person sees on Yappn is in their language, regardless of the language in which it was initially posted.

In May of 2017, Yappn announced that it was granted a new patent for "Cross-Language Communication Between Proximate Mobile Devices" from the Commissioner of Patents representing the Canadian Patent Office. In addition, the patent was also separately granted in the United States on June 9, 2015 as Patent No. US 9,053,097 B2. Canadian Patent No. 2,835,110 was granted on April 11, 2017. It was received by Yappn on May 3, 2017.

Yappn Corp. (YPPN), closed Thursday's trading session at $0.0145, down 46.30%, on 2,061 volume with 2 trades. The average volume for the last 60 days is 5,519 and the stock's 52-week low/high is $0.006/$0.15.

HedgePath Pharmaceuticals, Inc. (HPPI)

BUYINS.NET, MarketWatch, InvestorsHub, and Stockhouse reported earlier on HedgePath Pharmaceuticals, Inc. (HPPI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

HedgePath Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It discovers, develops, and plans to commercialize leading-edge therapeutics for patients with cancer. The Company is looking to repurpose the Food and Drug Administration (FDA) approved antifungal pharmaceutical itraconazole as a potential treatment for cancer. HedgePath Pharmaceuticals is headquartered in Tampa, Florida.

HedgePath is the exclusive U.S. licensee of a patented formulation of itraconazole, named SUBA-Itraconazole. Clinical studies have shown it to have more bioavailability than generic itraconazole. The Hedgehog signaling pathway is a significant regulator of cellular processes in vertebrates. This includes cell differentiation, tissue polarity, as well as cell proliferation.

HedgePath Pharmaceuticals believes (based on published research) that inhibiting the Hedgehog pathway could delay or possibly prevent the development of certain cancers in humans. Leveraging research undertaken by key investigators in the field, the Company’s plan is to explore the effectiveness of SUBA-Itraconazole as an anti-cancer agent and to pursue its potential commercialization.

The design of “SUBA technology” (which stands for “super bioavailability”) is to improve the bioavailability of orally administered drugs that are poorly soluble. SUBA-Itraconazole is a patented formulation developed by Mayne Pharma. It has improved absorption and substantially reduced variability in comparison to generic itraconazole.

In July of 2017, HedgePath Pharmaceuticals announced that the FDA provided further guidance concerning the Company’s continuing, open-label Phase 2(b) clinical trial studying the effect of SUBA-Itraconazole (SUBA-Cap) oral capsules in patients with Basal Cell Carcinoma Nevus Syndrome (BCCNS), also known as Gorlin Syndrome. BCCNS results from a genetic mutation that causes the Hedgehog pathway (a major regulator of processes in cells) to function improperly, leading to the chronic formation of basal cell tumors.

The FDA's guidance came in the form of a written response by the FDA to HedgePath Pharmaceuticals’ Type-C meeting background package. Such a meeting is a standard element of the regulatory review process leading to a potential New Drug Application (NDA) to the FDA.

This past October, HedgePath Pharmaceuticals announced that it completed enrolment in its earlier announced open label, Phase 2(b) SCORING clinical trial, testing SUBA™-Itraconazole in patients with BCCNS (Basal Cell Carcinoma Nevus Syndrome - or Gorlin Syndrome).

Recently, HedgePath Pharmaceuticals announced that it entered into a definitive preferred stock and warrant Securities Purchase Agreement with its majority stockholder Mayne Pharma.

Mayne Pharma agreed to invest up to $5 million in HedgePath Pharmaceuticals, the first $2.4 million of which was received by the Company on January 10, 2018, with a second tranche of $1.6 million to be funded by mid-2018, and a third tranche to be funded by year end if HedgePath Pharmaceuticals’ pending New Drug Application (NDA) for the SUBA-Itraconazole treatment of Basal Cell Carcinoma Nevus Syndrome (BCCNS) is accepted for filing by the FDA.

HedgePath Pharmaceuticals, Inc. (HPPI), closed Thursday's trading session at $0.2899, even for the day. The average volume for the last 60 days is 6,553 and the stock's 52-week low/high is $0.1923/$0.4701.

Investview, Inc. (INVU)

Stockhouse, OTC Markets, Barchart, MarketWatch, InvestorsHub, Marketwired, Stockflare, Investopedia, TradingView, and StockDeputy reported on Investview, Inc. (INVU), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Incorporated in 2005, Investview, Inc. is a diversified financial technology company. It operates chiefly through its wholly- and majority-owned subsidiaries. Investview provides financial products and services to accredited investors, self-directed investors, as well as select financial institutions. The Company has its Wealth Generators wholly-owned subsidiary.

Investview has its corporate office in Salt Lake City, Utah. The Company formerly went by the name Global Investor Services, Inc. It changed its name to Investview, Inc. in March 2012. The Company lists on the OTCQB.

Wealth Generators’ products are provided to individuals on a monthly subscription basis. Wealth Generators is classified as a publisher of financial research and information and it is exempt from securities registration.

Investview’s Wealth Generators provides financial technology, education, and research to individuals. Wealth Generators is not a brokerage firm or Registered Investment Advisor. It does not execute trades or take possession of clients' brokerage accounts. Its products undergo distribution via a direct sales model.

Through Wealth Generators, Investview provides education and technology designed to help individuals in navigating the financial markets. The Company’s services include tools and research, newsletter alerts, and live education rooms that comprise instruction on the subjects of equities, options, FOREX, ETF’s, and binary options. Furthermore, Investview offers education and technology applications to help individuals in debt reduction, enhanced savings, budgeting, and proper tax expense management.

Investview has completed its initial launch of Wealth Generator (WG) Startups that provides education and analysis of the crowdfunding marketplace. The initial webinar was delivered live by WG Startups Market Expert, Mr. Michael Markowski, on October 5, 2017 for Wealth Generators members.

Investview, via its wholly owned subsidiary Wealth Generators, has added Crypto mining services and education to its program services. Wealth Generators has entered into a definitive agreement to offer crypto mining equipment and algorithmic software to Wealth Generators customers.

Mr. Ryan Smith, Investview Chief Executive Officer, said in November 2017, "Working with specialists in cryptocurrency we have arranged access to high powered mining farms for our members through our new product called Crypto. By providing education and access to leading edge technology our members can participate in the forefront of the cryptocurrency movement without the enormous costs of equipment, programming and on-going operations."

In December, Investview announced that Wealth Generators generated roughly $1 million in product sales from its crypto mining product launched in November 2017. Wealth Generators offers crypto currency mining leases for a term of 1,200 days with an entry-level package priced at $499.

Yesterday, Investview announced that it will hold a Live Webinar on January 16, 2018, 3:00 PM Eastern Time to update Shareholders on the Company’s status and recent achievements since the acquisition of Wealth Generators in March of 2017.

Investview, Inc. (INVU), closed Thursday's trading session at $0.026, up 9.24%, on 99,336 volume with 13 trades. The average volume for the last 60 days is 229,998 and the stock's 52-week low/high is $0.0027/$0.10.

Enertopia Corp. (ENRT)

Penny Stock General, Shiznit Stocks, Cannabis Financial Network News, PennyStocks24, Fast Money Alerts, Stock Shock and Awe, Penny Champions, Equities, MassiveStockProfits, Wall Street Equities Research, Stockgoodies, GrowthPennyStocks, and Penny Dreamers reported earlier on Enertopia Corp. (ENRT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Enertopia Corp. is exploring a portfolio of three prospective lithium projects in the State of Nevada. Additionally, at the same time, the Company is working with water purification technology believed to be able to recover Lithium from brine solutions. Enertopia has its corporate office in Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQB.

Enertopia announced in April 2017 the formation of a Lithium business division for the exploration of Lithium. In May 2017, it closed the definitive agreement for the Lithium exploration project in Nevada.

In June 2017, Enertopia announced its Surface Exploration Program in Nevada. In Nevada, the Company has 2,560 acres of placer mining claims staked in Edwards, Smith and Big Smoky valleys.

The Central Nevada Lithium Brine Projects are proximal to an existing lithium mine. There is all weather access on paved roads and it is an ideal evaporation climate.

Genesis Water Technologies (GWT) is a partner of Enertopia. GWT is a manufacturer of advanced, innovative and sustainable treatment solutions for applications in process water, drinking water, water reuse and waste water for the energy, agriculture processing, industrial, municipal infrastructure, and building/hotel sectors.

Since September 2017, GWT has been evaluating data obtained from the first bench test results and other technical data provided by Enertopia to complete a larger and enhanced lithium recovery system. This $200,000 pre-paid second phase bench test is now complete. The second phase of the second bench test will use synthetic brine solutions, which will be created from the surface samples from the two bulk samples taken at Enertopia’s Clayton Valley project.

The next steps for the Company in 2018 are a bench test build out this month and preparation of synthetic brines in February. In March and April, bench testing of synthetic lithium brines will take place. In May will be final laboratory lithium recovery and Li2CO3 grade results.

Enertopia Corp. (ENRT), closed Thursday's trading session at $0.064, up 8.47%, on 127,653 volume with 18 trades. The average volume for the last 60 days is 307,685 and the stock's 52-week low/high is $0.032/$0.125.

graphic

The QualityStocks
Company Corner

graphic
graphic

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P)

The QualityStocks Daily Newsletter would like to spotlight Liberty Leaf Holdings Ltd. (LIBFF). Today, Liberty Leaf Holdings Ltd. closed trading at $0.3494, up 10.22%, on 40,590 volume with 23 trades. The stock’s average daily volume over the past 60 days is 189,403, and its 52-week low/high is $0.0091/$0.8074.

Will Rascan, President and CEO of Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) ("Liberty Leaf" or "the Company"), announced today the signing of an agreement between North Road Ventures, a wholly-owned subsidiary of the Company, and Cannabis Compliance Inc. Also today, Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) and Blox Labs, Inc. (CSE: BLOX) (OTC: BLLXF) have announced progress on their joint development of phase one of cannaBLOX, the blockchain-based smart contract platform for the legalized cannabis industry (http://nnw.fm/lw2qG).

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF), is a publicly traded Canadian-based company with strategic investments in businesses that are established, revenue- producing players in the medicinal and recreational cannabis market. Liberty Leaf’s focus is to build and support a diversified portfolio of cannabis-sector businesses, including those involved in the cultivation and processing of legal medicinal and recreational cannabis, value-added CBD/THC pet products, and supply-chain products for this dynamic and fast-growing sector. Liberty Leaf provides funding, management, HR resources and marketing expertise to help companies thrive and accelerate growth.

Liberty Leaf’s leading investments to date include:

  • North Road Ventures – An emerging end-to-end distributor of cultivated and manufactured cannabis products to licensed legal retailers. North Road has updated its application for an Access to Cannabis for Medical Purposes Regulations (ACMPR) license to be distribution/sales-focused, making the company unique in the crowded field of other cultivation-based applicants. This forward-thinking initiative will help fulfill the anticipated increase in Canada’s recreational cannabis space once legalization takes effect in mid-2018. The submission includes a boost in product-vault capacity that will result in a five-fold increase in products available for distribution. Cannabidiol (CBD)-oil products are expected to account for 50 percent or more of projected sales.
  • Just Kush Enterprises – Liberty Leaf holds a 60 percent interest in Just Kush, a cultivator of premium, proprietary cannabis strains selected for different levels of CBDs and THCs. Just Kush’s cultivation facility is located near Oliver, British Columbia, and it currently controls a facility which holds a Medical Marihuana Access Regulations (MMAR) license. The company is also a late-stage applicant for an ACMPR license (Access to Cannabis for Medical Purposes Regulations), which will enable Just Kush to produce cannabis for the medicinal and recreational market.

Liberty Leaf is also an active partner with the following companies:

  • ESEV R&D – A privately owned, medical marijuana research and development company based in New York with clinical laboratories located in Israel. ESEV R&D, in collaboration with a leading clinical research organization in Israel, has launched a one-of-a-kind service for North American medical cannabis companies to organize and oversee clinical trials seeking to demonstrate the efficacy of medical cannabis products for specific medical conditions. Liberty Leaf has a three-year collaborative agreement with ESEV. Under that agreement, ESEV is researching the efficacy of CBDs in pets, with the 1st formulation trial targeting canine osteoarthritis, a medical condition that includes: hip dysplasia; elbow dysplasia; and hind-knee, also known as stifle, degenerative joint disease (DJD).
  • Blox Labs Inc. – A boutique technology company focused on creating best-in-class smartphone apps and software solutions driven by emerging trends in blockchain, smart contracts and decentralized application technologies. Liberty Leaf and Blox Labs are developing “cannaBLOX,” a blockchain-based smart contract supply chain management platform for the legalized cannabis industry.

The company’s management team is led by President and Director William Rascan who has 25-plus years in the investment brokerage industry, most recently as a partner, senior investment advisor with Northern Securities. Rascan’s business experience ranges from active international trading clients to raising capital for junior mining companies on the TSX Venture Exchange.

Rascan is joined by CFO Jamie Robinson, a chartered accountant who specializes in accounting, auditing, and financial reporting under both IFRS and ASPE. Prior to joining Liberty Leaf, Robinson worked at Deloitte as a manager focused on publicly listed and private company audits, business review, performance enhancement engagements and restructuring proceedings.

Steven Feldman, who has more than 25 years of experience in the capital markets and was part of the original management team of SouthGobi Resources; and Doug Macdonell, a retired RCMP officer and recognized expert in the field of cannabis and cultivation, serve as company directors. Dr. Robert Jackman, who has worked closely with multiple clients in the medical cannabis and Natural and Non-prescription Health Products (NNHP) industries in North America, was recently appointed as scientific project manager/fulfillment.

Liberty Leaf’s advisory board includes international lawyer, writer and speaker Robert W.E. Laurie; Barinder Rasode, who currently serves as CEO of the National Institute for Cannabis Health & Education (NICHE); and Dr. Mary C. Fitzpatrick, B.S., D.V.M., whose primary focus is on helping companion animals live pain free in their senior years. Disclaimer

Liberty Leaf Holdings Ltd. Company Blog

Liberty Leaf Holdings Ltd. News:

Liberty Leaf Holdings' Subsidiary North Road Ventures Signs Agreement with Cannabis Compliance Inc. to Facilitate In-House GMP-Compliant Manufacturing

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) and Blox Labs, Inc. Near Completion of cannaBLOX White Paper

Liberty Leaf Holdings and Blox Labs Provide Update on Cannabis Blockchain Project "cannaBLOX"

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.0213, up 9.23%, on 5,138,808 volume with 199 trades. The stock’s average daily volume over the past 60 days is 15,764,718, and its 52-week low/high is $0.0141/$0.16.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Global Payout, Inc. (GOHE), a client of NNW and a leading provider of comprehensive and customized prepaid payment solutions for domestic and international organizations distributing money worldwide. To view the full publication, titled “Blockchain Takes Center Stage in Payment Processing Revolution,” visit: http://nnw.fm/KeGG1. Also today, the company was pleased to announce that subsidiary MoneyTrac’s PotSaver brand has expanded its sales force and advertising net to include businesses outside of cannabis throughout the communities it serves with the intent of delivering more value to its growing base of patrons and subscribers.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

NetworkNewsWire Announces Publication on Contenders Transforming Payment Processing with Blockchain

Cannabis: The New California Gold Rush Brings Expansion to GOHE MoneyTrac's PotSaver Brand

CannabisNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Announces Launch of Integrated Philanthropic Company

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF). Today, Choom Holdings Inc. closed trading at $0.6265, up 8.02%, on 67,731 volume with 49 trades. The stock’s average daily volume over the past 60 days is 51,798, and its 52-week low/high is $0.1099/$0.8612.

CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing Choom Holdings Inc, (CSE:CHOO) (CNSX:CHOO) (CSE:CHOO.CN) (OTCQB:CHOOF), a Canadian company that is committed wholeheartedly to the recreational marijuana market.

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s "Choom Gang," a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with "choom," the local's term for marijuana. Choom's trademark slogans pivot off another unconventional phrase ("Say Hello to…"), bringing a heady dose of good times and good friends together as the company invites investors to "Say Hello to Choom™" as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company's first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom's initial license applications to ensure the company's readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company's character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1's revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic "Aloha" vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company's growth strategy. Get ready to "Say Hello" to opportunity, good times and good friends with Choom™. Disclaimer

Choom Holdings Inc. Company Blog

Choom Holdings Inc. News:

Choom Crystallizes Commitment to Recreational Branding with New Hire -- CFN Media

Choom™ Appoints Chris Gagan as SVP Marketing

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Evokes Good Times Vibe in Build up to Canadian Marijuana Legalization

Skinvisible, Inc. (SKVI)

The QualityStocks Daily Newsletter would like to spotlight Skinvisible, Inc. (SKVI). Today, Skinvisible, Inc. closed trading at $0.002242745, up 4.67%, on 77,250 volume with 9 trades. The stock’s average daily volume over the past 60 days is 213,417 and its 52-week low/high is $0.02/$0.33.

Opioids are taking a toll on the nation. A major contributing factor to the alarming statistics has been the increasing appearance of the synthetic opioid, fentanyl. A problem which shines a light on the proposed merger between Skinvisible, Inc. (OTCQB: SKVI) and Quoin Pharmaceuticals Limited. The combined entity’s proposed first product candidate, QRX001, is expected to be developed for the treatment of post-surgical pain.

Skinvisible, Inc. (SKVI) through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., is a Research and Development company whose patented Invisicare® technology can be used to revitalize or create new medical or skincare products, allowing a company that licenses Skinvisible's formulations to sell their own patented product and combat generic competitors.

A prescription dermatology product can generate $100 million or more a year, with the potential to lose 50-90% of that revenue when it goes off patent. Preserving that revenue is why the licensing of a product made with Invisicare is a very desirable option for many companies. The Company has developed a pipeline of 40 products using Invisicare, with a primary focus on optimizing the performance and increasing the value of "gold standard" dermatology drugs and licensing them to international and multi-national companies in the pharmaceutical, over-the-counter and cosmeceutical markets.

Invisicare® is a high performance topical and transdermal delivery system which enhances the delivery of drugs and other ingredients to and through the skin. The key to Skinvisible's patented technology and trademarked Invisicare® family of polymer delivery vehicles is its formula and process for combining hydrophilic and hydrophobic polymers into stable complexes in water emulsions. Invisicare® can be a key component of life cycle management, extending the life with a new patent-protected product, dramatically expanding the company's revenue stream.

Independent studies of Invisicare® have shown the following benefits:

  • Active ingredients stay on the skin for up to four hours or more and resist wash off and rub off.
  • Delivery method results in improved efficacy, reduced skin irritation and lower required dosage.
  • Unique formulations are non-drying and provide the ability to control the release of active ingredients.
  • Products form a protective barrier, which means normal skin respiration and perspiration occur and the product wears off as part of the skin's natural exfoliation process.

Terry Howlett, President, founder and CEO of Skinvisible Inc., said the Company has more than 15 years of scientific research and product development experience. All development is conducted using stringent pharmaceutical standards. The Company has licensed a number of its formulations including a prescription hemorrhoid cream in the USA, its anti-aging Kintari® line of products and DermSafe®, its non-alcohol hand sanitizer to a licensee in China. Producing licensed products for the booming cannabis industry is also an important element of the company's business strategy.

Skinvisible's foray into the rapidly expanding market for medicinal and recreational cannabis products is already underway with the development of the company's first hemp-derived CBD (cannabidiol) products. Skinvisible has negotiated an exclusive licensing deal in Canada with Canopy Growth Corporation, one of the world's leading cannabis companies. As part of the company's overall growth strategy, Skinvisible is also negotiating with a Licensed Producer in Las Vegas where Skinvisible scientists will develop THC (tetrahydrocannabinol) products for the legal recreational and medical marijuana market for the USA. Notably, Skinvisible is actively pursuing potential licensees through-out the world where medical cannabis is legal. These licensees will have the exclusive right to manufacture and distribute Skinvisible's cannabis products within their territory.

"We are excited about the results we are already seeing just with our hemp-derived CBD products," Howlett says. "Our science shows that our CBD products release almost four times that of market leaders and our transdermal product had an 81% penetration rate at 6 hours. These results are significant and provide the difference between ordinary cannabis products and ones enhanced by Invisicare."

The Company's business model includes out-licensing its formulations for a development fee, license fee and on-going royalties in addition to selling its Invisicare polymers to its licensees. Disclaimer

Skinvisible, Inc. Blog

Skinvisible, Inc. News:

Skinvisible, Inc.’s (SKVI) Potential Merger Set to Deliver an Alternative as Opioid Crisis Deepens

Skinvisible, Inc.’s (SKVI) Topical Delivery Tech Provides Effective Protection against Deadly Flu Viruses

NetworkNewsBreaks – Skinvisible, Inc. (SKVI) Preparing to Enter the Post-Surgical Pain Management Market through Proposed Merger

Lexaria Bioscience Corp. (CSE:LXX) (OTCQB:LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP). Today, Lexaria Bioscience Corp. closed trading at $1.385, up 1.09%, on 86,250 volume with 132 trades. The stock’s average daily volume over the past 60 days is 489,121 and its 52-week low/high is $0.27/$2.54.

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) continues to generate revenue from licensing its proprietary and patented technology DehydraTECH™, which is already patented in the U.S. and Australia. The company also has multiple patents pending in more than 40 countries globally. Lexaria’s entry into a seven-year definitive licensing agreement with Cannfections Group, Inc. in Canada is a major step toward bringing its improved delivery methodologies to market (http://cnw.fm/U1z45).

Lexaria Bioscience Corp. (LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body's gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria's products and others on the market is the company's disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the "unusual" taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company's technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria's processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government's National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria's unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience's business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company's patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria's lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world's most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria's revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company's growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets. Disclaimer

Lexaria Bioscience Corp. Blog

Lexaria Bioscience Corp. News:

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Seven-Year Licensing Agreement with Cannfections Group, Inc.

NetworkNewsAudio Covers Global Licensing Agreement of Lexaria Bioscience Corp. (CSE:LXX) (OTCQX:LXRP) and NeutriSci International Inc. (TXS-V:NU) (OTCQB:NRXCF)

Lexaria Enters Licensing Agreement with Cannabis Edibles Infusion Company

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF). Today, PreveCeutical Medical Inc. closed trading at $0.3446, up 0.94%, 31,838 volume with 15 trades. The stock’s average daily volume over the past 60 days is 15,088, and its 52-week low/high is $0.01/$0.80.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring PreveCeutical Medical Inc. (OTCQB:PRVCF) (CSE:PREV) (FSE:18H), a client of NNW and health sciences company that develops innovative preventive therapies utilizing organic and nature identical products. To view the full publication, titled “Gene Therapy Holds Out Hope for Diabetics,” visit: http://nnw.fm/7lg0F.

PreveCeutical Medical Inc. (PRVCF), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word "PreveCeutical" – a combination of the words "preventive" and "pharmaceutical" – was a precursor to the company's formation and incorporation in October 2015.

The company's first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical's research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical's gene-silencing technology would effectively "turn off" the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical's science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland's (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.'s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company's core. Disclaimer

PreveCeutical Medical Inc. Company Blog

PreveCeutical Medical Inc. News:

NetworkNewsWire Announces Publication on Exciting Treatment Advancements Through Gene Therapy

Gene Therapy Holds Out Hope for Diabetics

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) CEO, Chief Research Officer Discuss Company’s Response to Opioid Epidemic

Reign Sapphire Corp. (RGNP)

The QualityStocks Daily Newsletter would like to spotlight Reign Sapphire Corp. (RGNP). Today, Reign Sapphire Corp. closed trading at $0.1375, off by 8.27%, on 30,775 volume with 6 trades. The stock’s average daily volume over the past 60 days is 61,644, and its 52-week low/high is $0.0519/$0.325.

Reign Sapphire Corp., (OTCQB: RGNP), a direct-to-consumer, branded and custom jewelry company today announced the launch of Coordinates’ Delta Collection, a line of men’s jewelry with our signature engraved location coordinates in Sterling Silver and 14k Gold..

Reign Sapphire Corp. (RGNP), is a direct-to-consumer, custom and branded jewelry company headquartered in Los Angeles, California. Reign's mission is to provide ethical and sustainable jewelry direct to the modern consumer, marketed through sophisticated digital initiatives that speak directly to individuals through social media channels and personalized promotions. The company's lean operating model ensures expenses are linked to order flow with flexible production schedules targeting just-in-time delivery, which in turn reduces or eliminates commodity risk. Reign is a member of the American Gem Trading Association, which is committed to fair trade and processing of gemstones.

Reign Sapphire Corp. owns and operates three divisions: Reign Brands, Reign Ventures and Reign Blockchain. Reign Brands features four unique, niche jewelry brands with separate social media followings:

  • Reign Sapphires: Ethically produced, millennial-targeted sapphire jewelry sourced from Australia.
  • Coordinates Collection: Custom jewelry inscribed with location coordinates commemorating life's special moments.
  • Le Bloc: Classic, customized jewelry.
  • ION Collection by Jen Selter: Athleisure jewelry brand.

Reign Ventures is the company's joint venture platform for investment and development of jewelry technology-related products.

Reign Blockchain authenticates its sapphires as conflict-free, allowing customers to wear products created by a company that shares their beliefs in human dignity and environmental stewardship. In 2018, Reign Blockchain is preparing to conduct an initial coin offering (ICO) for ReignCoin, subject to regulatory approval. ReignCoin will serve as Reign's cryptocurrency as part of a blockchain-based loyalty reward program.

The company's products are sold through a commission-based affiliate program that is supported by personalized email campaigns and promotions, celebrity promotion and gifting, digital advertising based on keyword purchases and sponsored ads, and creative publicity events and media outreach to attract maximum exposure. The successful launch of a company-wide social media influencer campaign across all its retail brands boosted Reign's Instagram, Twitter and Facebook followings by double digits within the first three weeks of going live.

Reign continues to seek out international partnerships, adding to the success it has already achieved in the Middle East, where its flagship store is in the Dubai Mall. The company recently teamed up with the original founder of its Coordinates Collection brand, Owen de Vries, who will lead its Europe and United Kingdom sales efforts. The Netherlands-based operation will proliferate Reign point-of-sales that are adapted for local language, digital marketing and customer service.

Reign Sapphire Corp. is led by president and CEO Joseph Segelman, who has also served on the board of directors since December 2014. Segelman earlier served as the Chief Executive Officer and managing director of Australian Sapphire Corporation, Shefa Mining Corporation and Spencer Lloyd & Associates. He is an experienced marketing and operations professional with over 20 years of experience in logistics and marketing, and extensive experience in the Australian mining and gem industry. He is also a director and board member of OBK (a Sydney, Australia, based charity) and a Captain (Chaplain) in the Australian Army reserves. Segelman is the author of "Take Action: Successful Australians Share their Secrets." (Lothian Books, 2004).

The company's board of advisors includes Andrea Hansen, jewelry marketing veteran and former president of the Women's Jewelry Association; Jeremy Avitan, CPA and compliance executive; Michael Lawrence corporate lawyer and litigator, Doug Cole, corporate financier and entrepreneur, Thierry Chaunu, a luxury goods executive with prior senior management roles at Chopard, Christofle and Cartier, and Pinny Gwinisch, founder of Ice.com and adjunct professor at McGill and Rutgers University. Disclaimer

Reign Sapphire Corp. Company Blog

Reign Sapphire Corp. News:

Reign Sapphire Corp. Coordinates Collection Expands with New Men's Line in Sterling Silver and 14K Gold

Reign Sapphire Corp. (RGNP) Delivers Conflict-Free Gems Directly to Consumers

Reign Sapphire Corp. and StarShop Sign Marketing Agreement to Promote Top Social Media Influencer Brand

Epazz, Inc. (EPAZ)

The QualityStocks Daily Newsletter would like to spotlight Epazz, Inc. (EPAZ). Today, Epazz, Inc. closed trading at $0.1162, off by 2.36%, on 30,775 volume with 6 trades. The stock’s average daily volume over the past 60 days is 61,644, and its 52-week low/high is $0.0519/$0.325.

Epazz, Inc. (OTC: EPAZ), a leading provider of blockchain cryptocurrency mobile apps and cloud-based business software solutions, announced today that the company’s ZenaPay Bitcoin Ethereum wallet has been download more than 25,000 times since its launch on the Android Play Store. This is a major achievement given that the app was just launched on December 31, 2017. ZenaPay’s ranking in the Play Store has greatly improved. The increase in downloads is now publicly viewable on the Play Store here: https://play.google.com/store/apps/details?id=com.zenapay&hl=en

Epazz, Inc. (EPAZ), is a leading provider of blockchain cryptocurrency mobile apps and cloud-based business software solutions that specializes in providing customized web applications to the corporate world, higher education institutions and the public sector. The company's strategic expansion into the investment fintech software space can be seen in the recent acquisition of the android app CryptoFolio, which securely tracks and manages Bitcoin and Altcoin portfolios. Epazz, Inc., which acquired the software rights, source code and user base of CryptoFolio, plans to add additional cryptocurrencies and languages to the app, along with an iOS version to attract more users.

Epazz also offers ZenaPay Bitcoin wallet, which has been downloaded more than 10,000 times since its launch on the Play Store. A subsidiary of Epazz, ZenaPay is a financial technology company that offers a unique, secure and reliable Bitcoin payment app, allowing consumers to acquire Bitcoin at the point-of-sale. The consumer can then use this digital currency to make a purchase with ease. The CryptoFolio business model provides free features to attract users and then allows users to purchase additional features from $1.99 to $5.99 each. CryptoFolio is a great add-on app for ZenaPay, and future versions of CryptoFolio will include an option to download ZenaPay.

"We are starting 2018 with ZenaPay on both major mobile apps' platforms," said Shaun Passley, PhD, CEO and founder of Epazz. "We are in the processing of developing new blockchain technology which will introduce an additional source of revenue streams for our company."

Epazz technology makes it easy to convert legacy systems into cloud business process software, for which the company then charges an annual subscription fee. Epazz has acquired 11 software companies that have converted or are in the process of converting their legacy software products to cloud software using Epazz technology. Epazz then markets the new cloud-based solutions to new and existing customers.

Epazz's unique BoxesOS™ applications can create virtual communities for enhanced communication, provide information and content for decision-making, and create a secure marketplace for any type of commerce. Epazz has also filed a provisional patent for its new blockchain smart legal contract technology that reduces fraud in business transactional contracts. The technology allows for a transactional contract to become a living contract that is tracked and traced; it also verifies that a section of terms within a contract are followed and that all parties of an agreement obey the terms of the contract.

"Blockchain-based technology is the future of the Internet," Passley said. "Epazz will add blockchain technology to all of our products in the coming months using our blockchain cloud platform, BoxesOS. The company has been working with customers to understand the best uses of blockchain, and we are excited about filing the first of many blockchain patents, with many more to come." Disclaimer

Epazz, Inc. Company Blog

Epazz, Inc. News:

Epazz ZenaPay Blockchain Bitcoin Ethereum Wallet Has Been Downloaded More Than 25,000 Times Since Launch on the Play Store, Helping to Improve Its Ranking

NetworkNewsWire Releases Exclusive Audio Interview with Epazz, Inc.

IEG Holdings Corp. (IEGH) Projected to Reach $5.3M in Revenue in FY2019 by Equity Research Firm

PotNetwork Holdings Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holdings Inc. (POTN). Today, PotNetwork Holdings Inc. closed trading at $0.448, off by 3.55%, on 5,113,771 volume with 1,043 trades. The stock’s average daily volume over the past 60 days is 13,802,254, and its 52-week low/high is $0.0006/$0.957.

PotNetwork Holding, Inc. (OTC Pink:POTN) announced today that its wholly owned subsidiary, Diamond CBD, Inc., just one and a half months into the year has already reported that the Company has exceeded $3 Million in sales.

PotNetwork Holdings Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company's First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holdings.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies - Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies - Chill gummies are more robust than its counterpart, the "Relax" gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold - CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD - Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies - Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that's looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet - CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf - Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD - Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot - CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it's that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill - CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holdings continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holdings Inc. plans to expand its subsidiaries as well as make strategic acquisitions. Disclaimer

PotNetwork Holdings Inc. Company Blog

PotNetwork Holdings Inc. News:

PotNetwork Holding Inc. Generates Over $3,000,000 in Sales Over First 45 days of 2018

PotNetwork Reaches New Sales Milestones and Concentrates its Focus, Analysts Review and Target

PotNetwork Holding Inc. Exceeds 1 Million in Sales for First 15 Days of February

First Cobalt Corp. (TSX.V:FCC) (OTCQB:FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF). Today, First Cobalt Corp. closed trading at $0.8522, off by 6.88%, on 153,575 volume with 181 trades. The stock’s average daily volume over the past 60 days is 292,791, and its 52-week low/high is $0.3148/$1.3041.

First Cobalt Corp. (TSX-V: FCC, ASX: FCC, OTCQB: FTSSF) (the "Company") announces it has commenced its 2018 borehole geophysical and optical televiewer survey program to test holes drilled in Cobalt South and for the first time in Cobalt North. The borehole program is intended to expand known zones of cobalt mineralization and further define the controlling structures in these two areas.

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

First Cobalt Corp. Company Blog

First Cobalt Corp. News:

First Cobalt Commences Borehole Survey Program in Cobalt North and Cobalt South

NetworkNewsAudio Announces Audio Press Release (APR) on First Cobalt Corp. Moves to Meet Growing Demand for Cobalt

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) Set to Exploit Monopoly in Battery Grade Cobalt Refining

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Trader Power News
(TENX) +128.45%

2.

StockGuru
(SONT) +125.00%

3.

QualityStocks
(SEKZF) +62.67%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251